EGFR and non-small cell lung carcinoma: According to the specific cut-off point for high (> 10), medium (4 ~ 10), and low (< 4) levels of medication literacy, we found that the medication literacy level for NSCLC patients undergoing EGFR-TKI therapy was sub-optimal.